journal article·2014-12Open access

Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride

Vani Kalia, Tarun Garg, Gautam Rath, Amit Kumar Goyal

Abstract

The objective of this study was to develop an oral transmucosal formulation of an antiemetic drug that can not only serve in the active form but also provide a controlled release profile. In this study, sublingual films based on the biodegradable and water-soluble polymers, that is HPMCK-4M and PVPK-30, were developed by the solvent casting method, and were loaded with the antiemetic drug granisetron hydrochloride (granisetron HCl). The entrapment efficiency of the developed formulation was found to be 86%. The in vitro profile showed an instant release of the drug from the sublingual film, in a pattern following the first order kinetics array. The in vivo studies showed that granisetron HCl was delivered in its active state and showed effective results, as compared to its activity in the marketed formulation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Infant Health and Development · Nausea and vomiting management · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. 10.1016/j.ejps.2014.04.01310.1016/j.ejps.2014.04.013 ↗
2. Chaudhary S · J Drug Target · 2014 · 1
3. 10.1016/j.ejps.2013.11.01610.1016/j.ejps.2013.11.016 ↗
4. 10.3109/21691401.2014.91671510.3109/21691401.2014.916715 ↗
5. 10.2174/2210304x1120204000510.2174/2210304x11202040005 ↗
6. 10.1517/17425247.2014.89101410.1517/17425247.2014.891014 ↗
7. 10.2174/2210303111303666001510.2174/22103031113036660015 ↗
8. 10.2174/221030310399913121111041410.2174/2210303103999131211110414 ↗
9. 10.2174/2210304x1120204000310.2174/2210304x11202040003 ↗
10. 10.1615/CritRevTherDrugCarrierSyst.201401110410.1615/CritRevTherDrugCarrierSyst.2014011104 ↗
11. 10.1615/CritRevTherDrugCarrierSyst.v29.i110.1615/CritRevTherDrugCarrierSyst.v29.i1 ↗
12. 10.1615/CritRevTherDrugCarrierSyst.201300725910.1615/CritRevTherDrugCarrierSyst.2013007259 ↗
13. 10.1007/978-3-662-45775-7_410.1007/978-3-662-45775-7_4 ↗
14. 10.1615/CritRevTherDrugCarrierSyst.201400811710.1615/CritRevTherDrugCarrierSyst.2014008117 ↗
15. 10.1615/CritRevTherDrugCarrierSyst.201401012310.1615/CritRevTherDrugCarrierSyst.2014010123 ↗
16. 10.3109/10717544.2014.92876010.3109/10717544.2014.928760 ↗
17. Joshi D · Drug Deliv · 2014 · 1
18. 10.2174/2210303111303666001810.2174/22103031113036660018 ↗
19. 10.1615/CritRevTherDrugCarrierSyst.201400828510.1615/CritRevTherDrugCarrierSyst.2014008285 ↗
20. Kaur M · Drug Deliv · 2014
21. Kaur N · Drug Deliv · 2014 · 110.3109/10717544.2014.993486 ↗
22. Kaur P · Drug Deliv. · 2014 · 110.3109/10717544.2014.993486 ↗
23. Kaur R · Artif Cells Nanomed Biotechnol · 2014 · 1
24. Kaur R · Drug Deliv · 2014 · 110.3109/10717544.2014.993486 ↗
25. 10.1615/CritRevTherDrugCarrierSyst.201401052710.1615/CritRevTherDrugCarrierSyst.2014010527 ↗
26. Malik R · J Drug Target. · 2014 · 1
27. 10.3109/10717544.2014.93553210.3109/10717544.2014.935532 ↗
28. 10.1081/DDC-4394710.1081/DDC-43947 ↗
29. 10.3109/21691401.2014.92400710.3109/21691401.2014.924007 ↗
30. 10.3109/21691401.2014.92787910.3109/21691401.2014.927879 ↗
31. Nafee NA · Drug Dev Ind Pharm · 2004 · 30 · 98510.1081/DDC-200037245 ↗
32. Nibha KP · Int J Res Pharmaceut Biomed Sci · 2012 · 3 · 913
33. 10.1023/A:100758540378110.1023/A:1007585403781 ↗
34. 10.3109/21691401.2014.96619510.3109/21691401.2014.966195 ↗
35. Panzade P · Iran J Pharm Res · 2012 · 11 · 503
36. Prajapati V · Int J Pharm Tech Res · 2012 · 4 · 582
37. Pv S · Ind J Pharm Edu Res · 2011 · 45 · 242
38. Rohilla R · Drug Deliv. · 2014 · 110.3109/10717544.2014.945018 ↗
39. 10.4103/0250-474X.4145110.4103/0250-474X.41451 ↗
40. 10.4103/0250-474X.4033010.4103/0250-474X.40330 ↗
41. Sharma A · Artif Cells Nanomed Biotechnol · 2014 · 1
42. Sharma R · Artif Cells Nanomed Biotechnol. · 2014 · 1
43. 10.1615/CritRevTherDrugCarrierSyst.201400819310.1615/CritRevTherDrugCarrierSyst.2014008193 ↗
44. Singh B · Artif Cells Nanomed Biotechnol · 2014 · 1
45. Singh H · Artif Cells Nanomed Biotechnol · 2014
46. Singh O · J Pharm. · 2014 · 1